Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02229786Phase 2Completed
A Phase 2 trial of hyoscine butylbromide + paracetamol in Gastrointestinal spasms, sponsored by Boehringer Ingelheim. Started Feb 1998; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02229786.